The beauty health company SKIN.US Overview
SKIN AI Analysis & Strategy
Browsing restrictions can be lifted for a fee.
SKIN Current Performance
-12.30%
The beauty health company
-1.64%
Avg of Sector
-0.40%
S&P500
SKIN Key Information
SKIN Revenue by Segments
Browsing restrictions can be lifted for a fee.
SKIN Net Income
Browsing restrictions can be lifted for a fee.
SKIN Cash Flow
Browsing restrictions can be lifted for a fee.
SKIN Profit Margin
Browsing restrictions can be lifted for a fee.
SKIN PE Ratio River
Browsing restrictions can be lifted for a fee.
SKIN Financial Forecast
Browsing restrictions can be lifted for a fee.
SKIN Earnings Table
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | |||||||
| 2024Q4 | |||||||
| 2024Q3 | |||||||
| 2024Q2 | |||||||
| 2024Q1 |
SKIN Profile
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Price of SKIN
SKIN FAQ
When is SKIN's latest earnings report released?
The most recent financial report for The beauty health company (SKIN) covers the period of 2025Q1 and was published on 2025/03/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating SKIN's short-term business performance and financial health. For the latest updates on SKIN's earnings releases, visit this page regularly.
What is the operating profit of SKIN?
According to the latest financial report, The beauty health company (SKIN) reported an Operating Profit of -12.02M with an Operating Margin of -17.28% this period, representing a growth of 29.24% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is SKIN's revenue growth?
In the latest financial report, The beauty health company (SKIN) announced revenue of 69.58M, with a Year-Over-Year growth rate of -14.52%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much debt does SKIN have?
As of the end of the reporting period, The beauty health company (SKIN) had total debt of 567.69M, with a debt ratio of 0.84. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.
How much cash does SKIN have?
At the end of the period, The beauty health company (SKIN) held Total Cash and Cash Equivalents of 373.03M, accounting for 0.55 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does SKIN go with three margins increasing?
In the latest report, The beauty health company (SKIN) did not achieve the “three margins increasing” benchmark, with a gross margin of 69.8%%, operating margin of -17.28%%, and net margin of -14.5%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess SKIN's profit trajectory and future growth potential.
Is SKIN's EPS continuing to grow?
According to the past four quarterly reports, The beauty health company (SKIN)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -0.08. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
What is the FCF of SKIN?
The beauty health company (SKIN)'s Free Cash Flow (FCF) for the period is 1.85M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 109.92% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.